Cardiovascular Disease (Cardiology) · Columbus, GA
NPI
1013019512
Since 2006
Specialty
Cardiovascular Disease (Cardiology)
Code 174400000X
Group practices
3
Medicare group memberships
Hospitals
4
Hospital affiliations
2300 Manchester Expy Ste 1001, Butler Pavilion
Columbus, GA, 31904
Phone (706) 322-0528
Groups this clinician bills Medicare through
Medicare paid, 2024
$253K
3,259 services
Medicare patients, 2024
1,275
Average age 75
Drug cost, 2024
$1.4M
7,916 prescriptions
Company payments, 2025
$3,270
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Samir Mewar was code 99214 (office e&m - established), 821 times for 548 patients. In total Samir Mewar billed 3,259 services in 59 codes, and Medicare paid $253K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2013-10-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 821 | 548 | $84.65 | $69K |
| 93010 Electrocardiogram | Facility | 288 | 250 | $5.59 | $1,611 |
| 99213 Office E&M - Established | Office | 238 | 227 | $71.11 | $17K |
| 93306 Echocardiography (TTE/TEE) | Office | 219 | 219 | $140.04 | $31K |
| 93000 Electrocardiogram | Office | 170 | 162 | $9.54 | $1,621 |
| J2785 Injection, regadenoson, 0.1 mg | Office | 156 | 39 | $6.29 | $982 |
| 99232 Hospital E&M - Subsequent | Facility | 148 | 78 | $63.18 | $9,351 |
| 93296 External Electrocardiographic Monitoring | Office | 136 | 52 | $14.40 | $1,958 |
| 93306 Echocardiography (TTE/TEE) | Facility | 118 | 118 | $54.56 | $6,439 |
| 93294 External Electrocardiographic Monitoring | Office | 108 | 42 | $21.84 | $2,358 |
| 93015 Electrocardiogram | Office | 101 | 101 | $48.86 | $4,934 |
| 99222 Hospital E&M - Initial | Facility | 100 | 95 | $103.80 | $10K |
| 78452 Myocardial Perfusion Scan | Office | 90 | 90 | $308.03 | $28K |
| A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 89 | 89 | $96.54 | $8,592 |
| 99204 Office E&M - New | Office | 50 | 50 | $96.77 | $4,839 |
By year: 2022 $279K for 6,194 services; 2023 $275K for 4,617 services; 2024 $253K for 3,259 services.
Medicare prescription drug claims, 2024
In 2024, the drug Samir Mewar prescribed most often to Medicare patients was Ranolazine Er (Ranolazine), with 648 prescriptions and refills. In total Samir Mewar wrote 7,916 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ranolazine Er Ranolazine | 648 | 1,532 | 207 | $69K |
| Metoprolol Succinate Generic | 573 | 1,539 | 191 | $8,179 |
| Losartan Potassium Generic | 553 | 1,503 | 177 | $4,803 |
| Atorvastatin Calcium Generic | 494 | 1,423 | 175 | $4,055 |
| Eliquis Apixaban | 465 | 843 | 114 | $487K |
| Carvedilol Generic | 400 | 988 | 117 | $2,835 |
| Isosorbide Mononitrate Er Isosorbide Mononitrate | 362 | 997 | 127 | $3,759 |
| Furosemide Generic | 340 | 905 | 113 | $1,530 |
| Potassium Chloride Generic | 328 | 851 | 115 | $6,303 |
| Amlodipine Besylate Generic | 321 | 923 | 115 | $1,520 |
| Rosuvastatin Calcium Generic | 229 | 614 | 80 | $2,802 |
| Clopidogrel Clopidogrel Bisulfate | 199 | 568 | 69 | $1,869 |
| Nifedipine Er Nifedipine | 163 | 410 | 61 | $4,699 |
| Valsartan Generic | 148 | 402 | 42 | $5,439 |
| Nitroglycerin Generic | 124 | 145 | 51 | $1,965 |
Brand drugs: 1,132 claims; generic drugs: 6,784 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Samir Mewar $3,270 ($3,270 in general payments such as food, travel and fees) from 15 companies. The largest payer was Abbott Laboratories with $2,043.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 11 | $2,043 |
| Amgen Inc. AMGN | 6 | $170 |
| Novartis Pharmaceuticals Corporation NVS | 9 | $169 |
| CVRx, Inc. CVRX | 1 | $160 |
| Novo Nordisk Inc NVO | 8 | $156 |
| Merck Sharp & Dohme LLC MRK | 6 | $114 |
| Pfizer Inc. PFE | 5 | $95.14 |
| E.R. Squibb & Sons, L.L.C. BMY | 5 | $86.37 |
| AstraZeneca Pharmaceuticals LP AZN | 3 | $79.82 |
| Boston Scientific Corporation BSX | 1 | $56.96 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.